<img class="aligncenter wp-image-1541941 size-full" src="https://i0.wp.com/www.vanguardngr.com/wp-content/uploads/2021/02/e9261f9679062fed23ec8fe176cc7ab9.jpg?resize=600%2C324&#038;ssl=1" alt="Russia to register new Coronavirus vaccine CoviVac on February 20 – Officials" width="600" height="324" srcset="https://i0.wp.com/www.vanguardngr.com/wp-content/uploads/2021/02/e9261f9679062fed23ec8fe176cc7ab9.jpg?w=600&amp;ssl=1 600w, https://i0.wp.com/www.vanguardngr.com/wp-content/uploads/2021/02/e9261f9679062fed23ec8fe176cc7ab9.jpg?resize=300%2C162&amp;ssl=1 300w, https://i0.wp.com/www.vanguardngr.com/wp-content/uploads/2021/02/e9261f9679062fed23ec8fe176cc7ab9.jpg?resize=58%2C31&amp;ssl=1 58w, https://i0.wp.com/www.vanguardngr.com/wp-content/uploads/2021/02/e9261f9679062fed23ec8fe176cc7ab9.jpg?resize=260%2C140&amp;ssl=1 260w, https://i0.wp.com/www.vanguardngr.com/wp-content/uploads/2021/02/e9261f9679062fed23ec8fe176cc7ab9.jpg?resize=200%2C108&amp;ssl=1 200w" sizes="(max-width: 600px) 100vw, 600px" data-recalc-dims="1" /> The CoviVac vaccine, which was developed by Chumakov research centre, is expected to be registered on Feb. 20, the official Russian website with Coronavirus (COVID-19) data and advice said Thursday. “The registration of the vaccine is expected on Feb. 20,’’ the website said. Phase 2 of the research is expected to finish at the beginning of 2021. “After that, a mass trial of the drug with 3,000 volunteers is planned,’’ the website added. Russia on Tuesday declared itself the first country to approve a coronavirus vaccine with President Vladimir Putin saying one of his daughters had been inoculated. August 11, 2020 In "News" The efficacy of the Pfizer Coronavirus (COVID-19) vaccine (official name BNT162b2) might sustain against the newly-detected mutant strains from the United Kingdom (UK) and South Africa, a group of U.S. scientists said in a research paper.The paper was published on the BioRxiv website for biology research on Thursday. The research… January 8, 2021 In "Coronavirus Updates" India’s drugs regulator has recommended for emergency use, a locally developed coronavirus vaccine called Covaxin. Covaxin is expected to be a backup to the AstraZeneca/Oxford shot. Covaxin has been developed by Bharat Biotech, a company based in Hyderabad, with backing from the state-run Indian Council of Medical Research (ICMR). Not… January 3, 2021 In "News"